Tremella fuciformis polysaccharide, a major bioactive component in the edible medicinal mushroom, exhibits substantial health benefits, including enhancing the immune system, combatting tumors, and delaying aging.
Network Pharmacology
The study analyzed various fractions of Tremella fuciformis polysaccharide (TFPS) which is extracted from the "Yiner" mushroom under different conditions leading to variations in molecular weight. The TFPS comprises various monosaccharides including mannose, xylose, fucose, glucuronic acid, glucose, and galactose. One of the characterized structures consists of a linear mannose backbone with branched off chains of xylose, fucose and glucuronic acid. Biochemical, pharmacological, and clinical studies involving TFPS spanning 46 years (1972-2018) were drawn from the likes of PubMed, China National Knowledge Infrastructure and Wanfang database and comprehensively reviewed.
Over one hundred independent studies pointed to the multiple physiological and health-promoting effects of TFPS. These include benefits such as immunomodulation, antitumor, anti-oxidation, anti-aging, hypoglycemic, and hypolipidemic effects. An example of its practical application is its usage in enteric-coated capsules, approved by the Chinese Food and Drug Administration in 2002, to treat cancer patients suffering from leukopenia induced by chemotherapy and radiotherapy. This component is also used as a supplementary drug for the treatment of chronic persistent hepatitis and chronic active hepatitis, showing the versatility and progressive impact of TFPS.
View Article